Icahn School of Medicine At Mount Sinai Prime — New York, New York

Icahn School of Medicine At Mount Sinai Prime is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Icahn School of Medicine At Mount Sinai Prime has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Recurrent or Metastatic Solid Tumors.

Sponsors: Daiichi Sankyo.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Icahn School of Medicine At Mount Sinai Prime?

Icahn School of Medicine At Mount Sinai Prime has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Icahn School of Medicine At Mount Sinai Prime conducted?

Icahn School of Medicine At Mount Sinai Prime has 1 clinical trials on record, with 1 currently active. Their work covers Recurrent or Metastatic Solid Tumors.

Is Icahn School of Medicine At Mount Sinai Prime accredited by Crixeo Health?

Icahn School of Medicine At Mount Sinai Prime has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Icahn School of Medicine At Mount Sinai Prime?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.